Study Quantifies Exactly How Much THC Reaches the Fetal Brain During Pregnancy
Researchers measured THC in fetal tissues across trimesters, finding fetal brain THC reaches 35-50% of maternal blood levels, with a model predicting 3.7 nM THC from a 10mg inhaled dose.
Quick Facts
What This Study Found
Fetal brain/maternal plasma THC ratios: 0.50 (T1), 0.45 (T2), 0.35 (T3 umbilical). PBPK model: 10mg inhaled = 3.7 nM THC + 7.0 nM 11-OH-THC fetal brain. 10mg oral = 0.73 nM THC + 8.9 nM 11-OH-THC.
Key Numbers
Ratios: 0.50 (T1), 0.45 (T2), 0.35 (T3). 10mg inhaled: 3.7 nM THC. 10mg oral: 0.73 nM THC. N = 3, 14, 18.
How They Did This
Cannabinoid concentrations measured in maternal plasma and paired fetal tissues (T1-2) and umbilical plasma (T3). Verified maternal-fetal PBPK model. N = 3 (T1), 14 (T2), 18 (T3).
Why This Research Matters
Provides the actual human fetal exposure data needed to design accurate preclinical experiments and communicate concrete numbers to patients.
The Bigger Picture
A foundational study enabling calibration of animal experiments to realistic human fetal THC concentrations.
What This Study Doesn't Tell Us
Small T1 sample (n=3). Cross-sectional tissue collection. PBPK model assumptions. Unstandardized cannabis use patterns.
Questions This Raises
- ?Are these concentrations sufficient to activate CB1 receptors?
- ?How do levels differ with chronic vs. occasional use?
Trust & Context
- Key Stat:
- Fetal brain THC reaches 50% of maternal blood in trimester 1
- Evidence Grade:
- Direct human fetal tissue measurements with verified PBPK modeling. Small early-trimester samples add uncertainty.
- Study Age:
- 2025 Nature Communications study with novel fetal tissue data.
- Original Title:
- Quantification and prediction of human fetal (-)-Δ9-tetrahydrocannabinol/(±)-11-OH-Δ9-tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity.
- Published In:
- Nature communications, 16(1), 824 (2025)
- Authors:
- Kumar, Aditya R(2), Benson, Lyndsey S, Wymore, Erica M(4), Phipers, Jocelyn E, Dempsey, Jennifer C, Cort, Lucinda A, Unadkat, Jashvant D
- Database ID:
- RTHC-06871
Evidence Hierarchy
Enrolls participants and follows them forward in time.
What do these levels mean? →Frequently Asked Questions
How much THC reaches the fetal brain?
About 35-50% of maternal blood levels. A 10mg inhaled dose predicts 3.7 nM THC in fetal brain.
Does route of use matter?
Yes. Inhaled produces ~5x higher fetal brain THC than oral at the same dose, though oral produces more 11-OH-THC.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-06871APA
Kumar, Aditya R; Benson, Lyndsey S; Wymore, Erica M; Phipers, Jocelyn E; Dempsey, Jennifer C; Cort, Lucinda A; Unadkat, Jashvant D. (2025). Quantification and prediction of human fetal (-)-Δ9-tetrahydrocannabinol/(±)-11-OH-Δ9-tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity.. Nature communications, 16(1), 824. https://doi.org/10.1038/s41467-025-55863-5
MLA
Kumar, Aditya R, et al. "Quantification and prediction of human fetal (-)-Δ9-tetrahydrocannabinol/(±)-11-OH-Δ9-tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity.." Nature communications, 2025. https://doi.org/10.1038/s41467-025-55863-5
RethinkTHC
RethinkTHC Research Database. "Quantification and prediction of human fetal (-)-Δ9-tetrahyd..." RTHC-06871. Retrieved from https://rethinkthc.com/research/kumar-2025-quantification-and-prediction-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.